Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 8-K Event Regulation FD disclosure · Other events
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale SVP, Chief Financial Officer sold 446 shares at $1.72 ($769)
  8. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 726 shares at $1.72 ($1,252)
  9. 4 Planned sale CEO sold 15,192 shares at $1.72 ($26,196)
  10. 144 Insider Sale of Securities
  11. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  12. 8-K Event Regulation FD disclosure · Other events
  13. 8-K Event Regulation FD disclosure · Other events
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. ARS Other Annual Report to Security Holders
  18. DEFA14A Proxy Proxy Materials
  19. DEF 14A Proxy Proxy Statement
  20. 4 Derivatives Options or other derivatives

Page 5 of 37 · 731 filings